Empagliflozin surpasses glimepiride as metformin add-on

NEW ORLEANS – When used as an add-on therapy to metformin in patients with type 2 diabetes mellitus, empagliflozin has sustained safety and efficacy in reducing in hemoglobin A1c...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news